CB-103
- Generic Name
- CB-103
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H18N2O
- CAS Number
- 218457-67-1
- Unique Ingredient Identifier
- Q5BB91JL0V
- Background
CB-103 is under investigation in clinical trial NCT03422679 (Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath